• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5069686)   Today's Articles (37)
For: Giampieri M, Vanthuyne N, Nieddu E, Mazzei MT, Anzaldi M, Pedemonte N, Galietta LJV, Roussel C, Mazzei M. Asymmetric 4-aryl-1,4-dihydropyridines potentiate mutant cystic fibrosis transmembrane conductance regulator (CFTR). ChemMedChem 2012;7:1799-807. [PMID: 22927224 DOI: 10.1002/cmdc.201200311] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2012] [Indexed: 11/07/2022]
Number Cited by Other Article(s)
1
Jafari‐Chermahini MT, Tavakol H. One‐Pot Synthesis of Hantzsch 1,4‐Dihydropyridines by a Series of Iron Oxide Nanoparticles: Putative Synthetic TRPV6 Calcium Channel Blockers. ChemistrySelect 2021. [DOI: 10.1002/slct.202004390] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
2
Marengo B, Speciale A, Senatore L, Garibaldi S, Musumeci F, Nieddu E, Pollarolo B, Pronzato MA, Schenone S, Mazzei M, Domenicotti C. Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809. Mol Med Rep 2017;16:8849-8853. [PMID: 29039559 PMCID: PMC5779973 DOI: 10.3892/mmr.2017.7736] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Accepted: 07/27/2017] [Indexed: 01/12/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA